pyrazinamide has been researched along with Bowel Diseases, Inflammatory in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Excerpt | Relevance | Reference |
---|---|---|
" The paradoxical effect observed with probenecid was not seen in the E3040 dose-response curve for the uric acid excretion rate." | 1.30 | Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice. ( Furitsu, H; Iga, T; Kotaki, H; Sawada, Y; Yamada, H, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamada, H | 1 |
Kotaki, H | 1 |
Furitsu, H | 1 |
Sawada, Y | 1 |
Iga, T | 1 |
1 other study available for pyrazinamide and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.
Topics: Animals; Benzothiazoles; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inb | 1999 |